Koziolek M, Augustijns P, Berger C, Cristofoletti R, Dahlgren D, Keemink J
Pharmaceutics. 2023; 15(10).
PMID: 37896157
PMC: 10609725.
DOI: 10.3390/pharmaceutics15102397.
Chong T, Wong I, Cui J, Law M, Zhu X, Hu X
Int J Mol Sci. 2022; 23(21).
PMID: 36362047
PMC: 9653733.
DOI: 10.3390/ijms232113261.
Naseem A, Pal A, Gowan S, Asad Y, Donovan A, Temesszentandrasi-Ambrus C
Cells. 2022; 11(20).
PMID: 36291153
PMC: 9601193.
DOI: 10.3390/cells11203286.
Kell D
Molecules. 2021; 26(18).
PMID: 34577099
PMC: 8470029.
DOI: 10.3390/molecules26185629.
van Nuland M, Rosing H, Huitema A, Beijnen J
Clin Pharmacokinet. 2019; 58(10):1221-1236.
PMID: 31030372
DOI: 10.1007/s40262-019-00769-x.
Association between statin drug use and peripheral blood leukocyte telomere length in the National Health and Nutrition Examination Survey 1999-2002: a cross-sectional study.
Tran P, Meeker A, Platz E
Ann Epidemiol. 2018; 28(8):529-534.
PMID: 29853162
PMC: 6054912.
DOI: 10.1016/j.annepidem.2018.04.010.
In vitro P-glycoprotein activity does not completely explain in vivo efficacy of novel centrally effective oxime acetylcholinesterase reactivators.
Dail M, Meek E, Chambers H, Chambers J
Drug Chem Toxicol. 2018; 42(4):403-408.
PMID: 29722548
PMC: 6215530.
DOI: 10.1080/01480545.2018.1461902.
Comparison of In Vitro Assays in Selecting Radiotracers for In Vivo P-Glycoprotein PET Imaging.
Raaphorst R, Savolainen H, Cantore M, van de Steeg E, van Waarde A, Colabufo N
Pharmaceuticals (Basel). 2017; 10(3).
PMID: 29036881
PMC: 5620620.
DOI: 10.3390/ph10030076.
Development of a Novel Formulation That Improves Preclinical Bioavailability of Tenofovir Disoproxil Fumarate.
Watkins M, Wring S, Randolph R, Park S, Powell K, Lutz L
J Pharm Sci. 2016; 106(3):906-919.
PMID: 27986599
PMC: 5320394.
DOI: 10.1016/j.xphs.2016.12.003.
Differential expression of several drug transporter genes in HepG2 and Huh-7 cell lines.
Louisa M, Suyatna F, Wanandi S, Asih P, Syafruddin D
Adv Biomed Res. 2016; 5:104.
PMID: 27376043
PMC: 4918209.
DOI: 10.4103/2277-9175.183664.
Effects of Trichostatin A on drug uptake transporters in primary rat hepatocyte cultures.
Ramboer E, Rogiers V, Vanhaecke T, Vinken M
EXCLI J. 2015; 14:567-76.
PMID: 26648816
PMC: 4669911.
DOI: 10.17179/excli2015-220.
Effects of Cytochrome P450 3A4 Inhibitors-Ketoconazole and Erythromycin-on Bitopertin Pharmacokinetics and Comparison with Physiologically Based Modelling Predictions.
Boetsch C, Parrott N, Fowler S, Poirier A, Hainzl D, Banken L
Clin Pharmacokinet. 2015; 55(2):237-47.
PMID: 26341813
DOI: 10.1007/s40262-015-0312-0.
Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of liver technologies.
Usta O, McCarty W, Bale S, Hegde M, Jindal R, Bhushan A
Technology (Singap World Sci). 2015; 3(1):1-26.
PMID: 26167518
PMC: 4494128.
DOI: 10.1142/S2339547815300012.
Functional xenobiotic metabolism and efflux transporters in trout hepatocyte spheroid cultures.
Uchea C, Owen S, Chipman J
Toxicol Res (Camb). 2015; 4(2):494-507.
PMID: 25893091
PMC: 4384106.
DOI: 10.1039/c4tx00160e.
The physiological role of drug transporters.
Liang Y, Li S, Chen L
Protein Cell. 2015; 6(5):334-50.
PMID: 25797421
PMC: 4417677.
DOI: 10.1007/s13238-015-0148-2.
Pharmacokinetics and dose recommendations for cyclosporine and tacrolimus when coadministered with ABT-450, ombitasvir, and dasabuvir.
Badri P, Dutta S, Coakley E, Cohen D, Ding B, Podsadecki T
Am J Transplant. 2015; 15(5):1313-22.
PMID: 25708713
PMC: 5024008.
DOI: 10.1111/ajt.13111.
OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin.
Chen L, Shu Y, Liang X, Chen E, Yee S, Zur A
Proc Natl Acad Sci U S A. 2014; 111(27):9983-8.
PMID: 24961373
PMC: 4103324.
DOI: 10.1073/pnas.1314939111.
Organic anion-transporting polypeptides.
Stieger B, Hagenbuch B
Curr Top Membr. 2014; 73:205-32.
PMID: 24745984
PMC: 3996503.
DOI: 10.1016/B978-0-12-800223-0.00005-0.
Pharmacokinetic drug interactions of afatinib with rifampicin and ritonavir.
Wind S, Giessmann T, Jungnik A, Brand T, Marzin K, Bertulis J
Clin Drug Investig. 2014; 34(3):173-82.
PMID: 24399452
DOI: 10.1007/s40261-013-0161-2.
Interactions between tenofovir and nevirapine in CD4+ T cells and monocyte-derived macrophages restrict their intracellular accumulation.
Liptrott N, Curley P, Moss D, Back D, Khoo S, Owen A
J Antimicrob Chemother. 2013; 68(11):2545-9.
PMID: 23794601
PMC: 3797642.
DOI: 10.1093/jac/dkt225.